Patient included in an interventional study assessing treatment for active proctitis or distal proctosigmoiditis. 
Patient with left sided, colitis or pancolitis. 
Patient with severe proctitis (MAYO score ≥ 11 at inclusion). 
Patient previously treated with biologics. 
Patient treated with immunosuppressive within 1 month before study inclusion. 
Patient treated with corticosteroids within 2 weeks before study inclusion.       
    

NCT02368743_exc_T1
Condition
active proctitis
NCT02368743_exc_T2
Condition
distal proctosigmoiditis
NCT02368743_exc_T3
Procedure
treatment
NCT02368743_exc_T5
Scope
active proctitis or distal proctosigmoiditis
NCT02368743_exc_T6
Condition
colitis
NCT02368743_exc_T7
Condition
pancolitis
NCT02368743_exc_T8
Qualifier
left sided
NCT02368743_exc_T9
Scope
colitis or pancolitis
NCT02368743_exc_T10
Condition
proctitis
NCT02368743_exc_T11
Qualifier
severe
NCT02368743_exc_T12
Measurement
MAYO score
NCT02368743_exc_T13
Value
≥ 11
NCT02368743_exc_T14
Temporal
at inclusion
NCT02368743_exc_T15
Drug
biologics
NCT02368743_exc_T17
Temporal
previously
NCT02368743_exc_T18
Procedure
treated
NCT02368743_exc_T19
Drug
immunosuppressive
NCT02368743_exc_T20
Temporal
within 1 month before study inclusion
NCT02368743_exc_T21
Reference_point
study inclusion
NCT02368743_exc_T22
Drug
corticosteroids
NCT02368743_exc_T23
Temporal
within 2 weeks before study inclusion
NCT02368743_exc_T24
Reference_point
study inclusion